Case report
WBC 3.3 × 10
9 /l with 57% neutrophils, 1% eosinophils, 2% cord blood and for the transplantation procedure. The donor is healthy and no signs of anemia or developmental delay basophils, 4% monocytes, 35% lymphocytes, platelet count 335 × 10 9 /l, 0% reticulocyte, asparate aminotransferase have been observed on medical examination at 6 months, which was just before the patient received transplantation, 478 IU/l (normal 0-40 IU/l), alanine aminotransferase 272 IU/l (0-35 IU/l), serum iron 318 × 10 −5 g/l (85-and 14 months of age. 135 × 10 −5 g/l), serum ferritin 932 × 10 −5 g/l (5.5-18.5 × 10 −5 g/l). The bone marrow showed total absence of erythroid precursors with 70% myeloid cells, 27% lymphoDiscussion cytes and 4.7 × 10 7 /l megakaryocytes. His karyotype was 46, XY without any abnormalities, and he was positive for
We report a boy with Diamond-Blackfan anemia in whom normal erythroid hematopoiesis was restored after trans-CMV IgG.
The patient was isolated in a room with laminar airflow plantation of cord blood stem cells. To our knowledge, this is the first successful case of umbilical cord blood transand received nonabsorbable oral antibiotics, inhalations with tobramycin and amphotericin B, sulfamethoxazole/ plantation in a patient with Diamond-Blackfan anemia.
Umbilical cord blood has been utilized as an alternative trimethoprim, and acyclovir. CMV high-titer immunoglobulin was administered weekly from day −7 to day 180. Consource for hematopoietic reconstitution in patients with hematological and immunologic diseases since the first sucditioning was busulfan 3.5 mg/kg/day on days −9 to −6, equine anti-human thymocyte globulin (Lymphoglobuline, cessful report in Fanconi's anemia in 1988. 8 In view of the rapid progression of iron overload and lack of an HLAPasteur Mérieux, Lyon, France) 13 mg/kg/day on days −5 to −1, and cyclophosphamide 50 mg/kg/day on days −4 to matched elder sibling, our patient was transplanted with cord blood rather than bone marrow. −1. On day 0, cryopreserved umbilical cord blood was thawed and 3.8 × 10 7 /kg of nucleated cells containing Previously, allogeneic bone marrow transplantation has been considered as a primarily curative procedure for 8.7 × 10 5 CD34 + cells/kg, 3.6 × 10 4 CFU-GM/kg and 2.1 × 10 4 BFU-E/kg, were transplanted. For GVHD patients with transfusion-dependent Diamond-Blackfan anemia. However, complications resulting from previous prophylaxis CsA was started intravenously from day −1 and tapered off from 3 to 12 months. MTX 15 mg/m 2 was given sensitization of patients and iron overload has been reported in transfusion-dependent children. 4 In 16 cases of reported on day 1 and 10 mg/m 2 on days 3, 6, 11 and 18. For prophylaxis of veno-occlusive disease (VOD), prostaglandin E 1 Diamond-Blackfan anemia who received bone marrow transplantation, 2-5 four patients died (two, interstitial pneu-0.3 g/kg/h and heparin 100 U/kg were given intravenously with oral pentoxifylline 10 mg/kg from day −10 to day 9. monia, one, cardiac failure; one, chronic GVHD-related), graft rejection occurred in one patient, and acute and G-CSF 5 g/kg/day was given intravenously from day 1 to day 50. The patient had taken low-dose prednisolone for 2 chronic GVHD was observed in nine and seven patients, respectively. Because our patient was heavily transfused years before transplantation. Prednisolone was maintained at 10 mg on alternate days during transplantation and tapand liver hemosiderosis was present, antilymphocyte globulin was added to busulfan and cyclophosphamide for ered off on day 59.
The clinical course of the patient was uneventful. A total immunosuppression and heparin and prostaglandin E 1 was administered for prophylaxis of VOD. No regimen-related leukocyte count of 1.0 × 10 9 /l and an absolute neutrophil count 0.5 × 10 9 /l were achieved on day 29, and a reticulotoxicity was observed and engraftment occurred successfully with no signs of rejection. Successful engraftment cyte count of 100 × 10 9 /l on day 55. The platelet count exceeded 20 × 10 9 /l unsupported on day 72 and was without regimen-related toxicity in this patient may suggest that our preparative regimen is sufficient and tolerable for 50 × 10 9 /l on day 96. Red blood cells were last transfused on day 40 and platelets on day 64. Bone marrow examintransfusion-dependent patients. GVHD is another major issue affecting not only the ation on day 40 showed that the total nucleated cells were 81.5 × 10 9 /l, with 23% erythroid cells and 56% myeloid transplant course but also quality of life after transplantation. It has been reported that life-threatening GVHD cells; chromosomes were of a normal female karyotype in 20 of 20 cells. Complete chimerism was confirmed with occurs less frequently in patients transplanted with umbilical cord blood compared with bone marrow. 6 In this case, karyotyping in the peripheral blood on day 373. At 12 months, laboratory findings were as follows: hemoglobin no signs of acute and chronic GVHD were observed for 14 months. 141 g/l, WBC 8.5 × 10 9 /l with 40% neutrophils; IgG 8.24 g/l, IgA 0.48 g/l, IgM 1.98 g/l, and IgE 1.7 × 10 4 IU/l. It has been reported that the median number of nucleated cells and CFU-GM obtained from cord blood after red cell Examinations on the subsets, and PHA-induced proliferation of lymphocytes were normal. CT still showed a high depletion is 5.2 × 10 7 /kg (range 1-33) and 2.4 × 10 4 /kg (range 0.01-100), respectively, and it has also been shown but slightly decreased density of the liver parenchyma compared with previously, and serum transaminase, iron and that to neutrophil recovery does not correlate with the number of nucleated cells or CFU-GM infused. 6 The number ferritin had slightly decreased: aspartate aminotransferase 61 IU/l, alanine aminotransferase 59 IU/l, serum iron of CFU-GM infused into our patient, 3.6 × 10 4 /kg, is average and the slow hematopoietic recovery observed in this 212 × 10 −5 g/l, and serum ferritin 680 × 10 −5 g/l. No abnormal findings were observed on echocardiography. No signs patient is therefore not due to the low number of progenitor cells infused. of acute or chronic GVHD have developed up to 14 months, and performance status is 100%. Informed consent
In conclusion, this is the first case of successful umbilical cord blood transplantation to a patient with transfusionwas obtained from the parents for collecting the umbilical 
